Androstenedione Is the Preferred Androgen Source in Hormone Refractory Prostate Cancer--Letter

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-14-1123
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Hormone-Refractory Prostate Cancer

English

The Androgen Receptor and Signal-Transduction Pathways in Hormone-Refractory Prostate Cancer. Part 1: Modifications to the Androgen Receptor

BJU International
Urology
2005English

Therapeutic Approach to Hormone-Refractory Prostate Cancer

Oncology & Hematology Review (US)
2007English

CS4 Bone Lesions in Hormone Refractory Prostate Cancer (HRPC)

Japanese Journal of Urology
Urology
2006English

Achieving Treatment Goals for Hormone-Refractory Prostate Cancer With Chemotherapy

Oncologist
Cancer ResearchMedicineOncology
2005English

Low-Dose Docetaxel in Combination With Dexamethasone for Hormone-Refractory Prostate Cancer

Japanese Journal of Urology
Urology
2011English

Mp50-09 Luteinizing Hormone-Releasing Hormone Antagonist Reduce Serum Adrenal Androgen Levels in Prostate Cancer Patients

Journal of Urology
Urology
2016English

The Radiation Response of Androgen-Refractory Prostate Cancer Cell Line C4-2 Derived From Androgen-Sensitive Cell Line LNCaP

Asian Journal of Andrology
MedicineUrology
2010English

Palliative Radiotherapy for Local Progression of Hormone Refractory Stage D2 Prostate Cancer

Japanese Journal of Urology
Urology
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy